TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
CRLBF

Cresco Labs Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

0.636$ -1.3% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Income Statement

Cresco Labs Inc. (CRLBF) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 173 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CRLBF
Line item Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
6.4 8.1 12 16 21 30 36 41 66 94 153 171 178 210 215 218 214 218 210 200 194 198 191 188 184 184 180 176 166 164 165 162 151 173 651
3.1 3.8 4.0 -9.3 10 5.0 15 34 32 25 69 67 91 109 107 108 107 105 111 112 108 111 97 92 92 90 86 92 87 80 86 78 76 86 326
3.4 4.3 8.2 26 11 25 21 7.7 34 69 85 104 87 101 108 110 107 113 99 88 86 87 94 96 92 95 93 84 79 83 79 83 75 87 325
2.2 2.6 4.3 24 16 19 24 31 44 44 42 50 71 86 81 80 87 90 83 91 78 76 72 69 63 62 65 42 65 58 59 65 64 74 262
5.3 6.4 8.4 16 28 26 42 67 82 77 121 149 162 195 189 188 193 196 194 202 191 187 169 161 155 152 151 156 152 138 145 144 140 160 589
1.1 1.6 3.8 0.5 -7.1 4.3 -5.6 -26 -16 18 32 22 16 15 27 30 21 23 16 -2.9 3.6 11 22 27 29 32 29 20 14 25 20 18 11 13 62
0.0 0.0 0.0 0.9 0.9 2.4 1.6 4.6 8.5 10 12 11 12 12 14 15 15 15 16 15 16 20 15 15 15 15 16 14 16 14 15 16 15 16 62
1.3 2.0 3.9 0.9 -7.6 1.7 -4.0 -41 -10.0 8.6 18 -9.1 -8.6 16 -276 12 -0.9 15 15 -157 -11 -30 -119 13 16 -41 11 3.1 -0.9 2.7 -10 -87 -2.8 -3.6 -104
0.0 0.0 0.0 4.4 0.0 5.6 4.6 4.3 3.5 13 13 14 16 13 -12 24 23 24 19 24 – 14 – – – – – – – – – – – – –
1.0 1.4 2.9 -6.8 -6.2 -2.0 -7.0 -28 -7.4 -19 -7.5 -48 -29 -4.8 -271 -15 -27 -14 -9.8 -161 -28 -37 -116 2.6 -5.2 -54 -11 -4.4 -14 -16 -17 -88 -13 17 -101
– – – – – – – – 6.9 29 40 13 15 39 -250 36 26 45 46 -126 8.8 -9.9 – – – – – – – 31 20 -59 27 27 14

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?